Unilink Pharma Private Limited - Company Profile

It is a pharma private limited company based in Chennai-600017., Tamil Nadu, India, established in 2005.
2005 Chennai-600017., Tamil Nadu, India Active
Last Updated:
Access Report
About Unilink Pharma Private Limited

Unilink Pharma Private Limited, a active private limited company, was established on 23 February 2005 in Chennai-600017., Tamil Nadu, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24232TN2005PTC055459. Registered under ROC Roc Chennai. it is unlisted. It has an authorized capital of ₹3.00 Cr and a paid-up capital of ₹1.60 Cr.

Formerly known as Unilink Drugs And Pharmaceuticals Private Limited. It upholds a compliant status. Its leadership includes Sreenivasan Karunakaran (Whole-Time Director), Karunakaran Vijaya (Managing Director). Past directors included Sekar Donna Padman, Tpalanisamy, Ramkumar Palanisamy. It holds ₹23.53 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at New No.111, Old No.23Parthasarathypuram T Nagar, Chennai-600017., Tamil Nadu, 600017.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24232TN2005PTC055459

  • Registration Number

    055459

  • Incorporation Date

    23 February 2005

  • Authorized Capital

    ₹3.00 Cr

  • Paid-Up Capital

    ₹1.60 Cr

  • ROC Code

    Roc Chennai

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 3.00 Cr
  • Paid Up Capital ₹ 1.60 Cr
  • Company Age 21 Year, 1 Month
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 23.53 Cr
  • Revenue Growth **** 13.87%
  • Profit Growth **** -4.66%
  • Ebitda **** -18.30%
  • Net Worth 12.29%
  • Total Assets **** 18.84%
Company report

Unilink Pharma Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Unilink Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Unilink Pharma Private Limited?
Current Directors
Name Designation Appointment Date Status
Sreenivasan Karunakaran Whole-Time Director 02 Oct 2009 Current
Karunakaran Vijaya Managing Director 23 Feb 2005 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Whole-Time Director 03 Jun 2009 Past
Pramod Abcsdd Director 06 Dec 2021 Past
Pramod Abcsdd Whole-Time Director 03 Jun 2009 Past
Pramod Abcsdd Director 30 Sep 2016 Past
Pramod Abcsdd Director 01 Apr 2019 Past
Pramod Abcsdd Managing Director 31 Mar 2019 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Unilink Pharma.

Unilink Pharma Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 13.87% increase. The company also saw a slight decrease in profitability, with a 4.66% decrease in profit. The company's net worth Soared by an impressive increase of 12.29%.

Unilink Pharma revenue growth over time
Unilink Pharma profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 13.87%
*******
*******
*******
*******
Revenue from Operations
*******
 14.96%
*******
*******
*******
*******
Total Assets
*******
 18.84%
*******
*******
*******
*******
Profit or Loss
*******
 -4.66%
*******
*******
*******
*******
Net Worth
*******
 12.29%
*******
*******
*******
*******
EBITDA
*******
 -18.30%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Unilink Pharma?

In 2023, Unilink Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹235,300,000.00

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions
  • State Bank Of India : 17.89 Cr
  • Others : 3.00 Cr
  • Icici Bank Limited : 1.40 Cr
  • Icici Home Finance Company Limited : 1.24 Cr
Latest Charge Details
Date Lender Amount Status
30 May 2020 State Bank Of India ₹1.97 Cr Open
08 Jan 2020 Others ₹3.00 Cr Open
19 Mar 2014 Icici Bank Limited ₹1.40 Cr Open
01 Oct 2009 Icici Home Finance Company Limited ₹1.24 Cr Open
28 Mar 2005 State Bank Of India ₹15.92 Cr Open

Explore comprehensive loan charge details -

How Many Employees Work at Unilink Pharma?

Unlock and access historical data on people associated with Unilink Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Unilink Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Unilink Pharma's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Unilink Pharma
Recent Activity within the Organization
  • Annual General Meeting

    Unilink Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was recorded as a recent event.

  • Balance Sheet

    Progress on Unilink Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Chennai. was documented.

  • Charges

    A charge with State Bank Of India of Rs. 15.92 Cr registered on 28 Mar 2005 with Charge ID 80020355 was modified on 26 Mar 2024. was recorded as a recent event.

  • Charges

    The activity A charge with State Bank Of India amounted to Rs. 1.97 Cr with Charge ID 100367338 was registered on 30 May 2020. was completed.

  • Charges

    The activity A charge with Others amounted to Rs. 3.00 Cr with Charge ID 100313511 was registered on 08 Jan 2020. was completed.

  • Charges

    The activity A charge with Icici Bank Limited amounted to Rs. 1.40 Cr with Charge ID 10485266 was registered on 19 Mar 2014. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Unilink Pharma Private Limited?

The CIN of Unilink Pharma Private Limited is U24232TN2005PTC055459.

Where is Unilink Pharma Private Limited headquartered?

Unilink Pharma Private Limited is headquartered at New No.111, Old No.23Parthasarathypuram T Nagar, Chennai-600017., Tamil Nadu, 600017.

When was Unilink Pharma Private Limited incorporated?

Unilink Pharma Private Limited was incorporated on 23 February 2005.

Who are the current directors of Unilink Pharma Private Limited?

The current directors of Unilink Pharma Private Limited are

What is the primary industry of Unilink Pharma Private Limited?

The primary industry of Unilink Pharma Private Limited is Manufacturing.

Is Unilink Pharma Private Limited a listed company?

Unilink Pharma Private Limited is unlisted.

What is the capital structure of Unilink Pharma Private Limited?

The authorized capital of Unilink Pharma Private Limited is ₹3.00 Cr, and the paid-up capital is ₹1.60 Cr.

What is the compliance status of Unilink Pharma Private Limited?

The compliance status of Unilink Pharma Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available